Cardioselectivity reduces the risk of bronchospasm and peripheral vasoconstriction,
making it a preferable option in patients with asthma or COPD
Improves survival, reduces hospitalization, and enhances left ventricular ejection fraction (LVEF) by modulating sympathetic drive and reducing cardiac workload.
Due to low lipophilicity, metoprolol has a minimal capacity to cross the blood-brain –
barrier, thereby significantly lowering the incidence of CNS adverse effects
We are dedicated to driving innovation in healthcare through cutting-edge research and biotechnological solutions. Our mission is to improve lives with science-backed therapies and a commitment to excellence.
F/10 Moonlight Complex,
Gurukul Road,
Ahmedabad - 380013
Gujarat, India
Sachin Patel
Sanjay Kumar Jaiswal
therapeiabiosciences@gmail.com
+91 99780 47841
